Patent · US Active

Material and methods for treating or preventing HER-3 associated diseases

US9803025B2 · kind B2 · utility

3Cited by

42References

38Claims

0Family size

Assignees

AMGEN INC. · US
DAIICHI SANKYO EUROPE GMBH · DE

Inventors

Thore Hettmann · Birkenfeld, DE
Daniel J. Freeman · Newbury Park, US
Robert Radinsky · Thousand Oaks, US

Key dates

Filing date	Apr 25, 2013
Grant date	Oct 31, 2017
Priority date	—
Expiry date	Feb 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigen-binding protein, or a small molecular tyrosine kinase inhibitor, for example.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.